https://health.economictimes.indiatimes.com/news/pharma/caplin-receives-us-fda-approval-for-generic-rocuronium-bromide-injection/98815840
Lupin: Caplin receives US FDA approval for generic Rocuronium Bromide Injection, ETHealthworld
Lupin: The injections are the generic version of Zemuron Bromide Injection, 50 mg/5 mL and 100 mg/10 mL of Organon USA Inc, and will be used as an adjunct to...
us fda approvalrocuronium bromide injection
https://www.pharmatutor.org/pharma-news/2015/sofgen-nimodipine-30mg-capsule-receives-us-fda-approval
Sofgen's Nimodipine 30mg capsule receives US FDA approval | PharmaTutor
ANI Pharmaceuticals, Inc., an integrated specialty pharmaceutical company, announced that its ANDA collaboration partner Sofgen, received approval from the US...
us fda approvalnimodipinecapsulereceives
https://www.marketscreener.com/news/us-fda-expands-approval-for-travere-therapeutics-drug-for-rare-kidney-disease-ce7e50dedf81f425
US FDA expands approval for Travere's drug for rare kidney disease | MarketScreener
Apr 14, 2026 - The U.S. Food and Drug Administration has approved the expanded use of Travere Therapeutics' drug to treat a rare kidney disorder, the company said on Monday....
us fda
https://www.worldpharmaceuticals.net/news/kite-yescarta-follicular-lymphoma/
Kite gets US FDA approval for Yescarta to treat follicular lymphoma - World Pharmaceutical Frontiers
Mar 8, 2021 - The company claimed that its Yescarta is the first chimeric antigen receptor (CAR) T-cell therapy approved for patients with indolent follicular lymphoma